All In Biotech

Drug Trial Radar · NCT07497087

A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis

A Double-blind, Randomised, Placebo-controlled Trial Evaluating the Efficacy and Safety of Oral Nerandomilast Treatment in Patients With Systemic Sclerosis (SSc)

Last checked: Nov 19, 2026Latest source record: Oct 14, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 448 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

448

Planned (sponsor's estimate)

Start

Jul 27, 2026

Primary completion

Feb 26, 2030

Study completion Mar 17, 2030

Sponsor

Lead sponsor
Boehringer IngelheimBoehringer Ingelheim
Sponsor type
Industry
First posted
Mar 27, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Nerandomilast is being developed to help people with systemic sclerosis by potentially improving symptoms and slowing disease progression. This study is open to adults who are at least 18 years old and have systemic sclerosis (SSc). People can join the study if they have limited or diffuse cutaneous SSc with disease onset within 7 years of the first non-Raynaud's symptom. The purpose of this study is to find out whether a medicine called nerandomilast helps people with systemic sclerosis. This study also aims to find out how well nerandomilast is tolerated in people with systemic sclerosis. Participants are put into 2 groups randomly, which means by chance. One group takes nerandomilast tablets and the other group takes placebo tablets. Placebo tablets look like nerandomilast tablets but do not contain any medicine. Participants take the tablets twice a day. Participants are in the study for 1 to about 4 years. During this time, they visit the study site regularly and get phone calls from the site staff. During study visits participants regularly have blood samples taken and doctors check changes in skin thickening, lung function, and internal organs, overall health and the safety and tolerability of study treatment in people with SSc. The results are compared between the groups to see whether the treatment works. The doctors also regularly check participants' health and take note of any unwanted effects.

Conditions

  • Systemic Sclerosis

Interventions

  • Placebo matching nerandomilast formulation 1Drug

    Film-coated tablets

  • Placebo matching nerandomilast formulation 2Drug

    Film-coated tablets

  • Nerandomilast formulation 1Drug

    Film-coated tablets

  • Nerandomilast formulation 2Drug

    Film-coated tablets

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Time to the first occurrence of disease progression or all-cause deathTime frame: up to 4 years

Locations

248 sites in 45 countries. Site status is shown where the registry gives one.

  • University of Alabama at Birmingham

    Birmingham, Alabama · Not yet recruiting

  • Banner - University Medicine Rheumatology Clinic

    Phoenix, Arizona · Not yet recruiting

  • Arizona Arthritis and Rheumatology Associates - Paradise Valley

    Scottsdale, Arizona · Not yet recruiting

  • University of California Los Angeles

    Los Angeles, California · Not yet recruiting

  • Paradigm Clinical Research - San Diego

    San Diego, California · Recruiting

  • Stanford University School of Medicine

    Stanford, California · Not yet recruiting

  • Medvin Clinical Research-Whittier-69033

    Whittier, California · Recruiting

  • University of Colorado Denver

    Aurora, Colorado · Not yet recruiting

  • Georgetown University

    Washington D.C., District of Columbia · Not yet recruiting

  • Millennium Research - Ormond Beach

    Ormond Beach, Florida · Recruiting

  • Integral Rheumatology and Immunology Specialist

    Plantation, Florida · Not yet recruiting

  • BioResearch Partner - South Miami

    South Miami, Florida · Recruiting

  • Northwestern University

    Chicago, Illinois · Not yet recruiting

  • The University of Chicago Medical Center

    Chicago, Illinois · Not yet recruiting

  • DelRicht Research-New Orleans-64100

    New Orleans, Louisiana · Recruiting

  • Johns Hopkins Hospital

    Baltimore, Maryland · Not yet recruiting

  • Massachusetts General Hospital

    Boston, Massachusetts · Not yet recruiting

  • University of Michigan

    Ann Arbor, Michigan · Not yet recruiting

  • Clinical Research Institute of Michigan, LLC - St. Clair Shores

    Saint Clair Shores, Michigan · Recruiting

  • M Health Fairview University of Minnesota Medical Center

    Minneapolis, Minnesota · Not yet recruiting

  • Rutgers Robert Wood Johnson Medical School

    New Brunswick, New Jersey · Recruiting

  • Hospital for Special Surgery

    New York, New York · Not yet recruiting

  • Icahn School of Medicine at Mount Sinai

    New York, New York · Not yet recruiting

  • Columbia University Medical Center-New York Presbyterian Hospital

    New York, New York · Not yet recruiting

  • University of Pennsylvania

    Philadelphia, Pennsylvania · Not yet recruiting

  • Thomas Jefferson University

    Philadelphia, Pennsylvania · Recruiting

  • West Tennessee Research Institute

    Jackson, Tennessee · Recruiting

  • Tekton Research, Inc - West Gate Boulevard

    Austin, Texas · Recruiting

  • Arthritis & Rheumatology Institute - Frisco

    Frisco, Texas · Recruiting

  • The University of Texas Health Science Center at Houston

    Houston, Texas · Not yet recruiting

  • Centro Medico Reumatologico - OMI

    CABA, Argentina · Recruiting

  • Mautalen- Salud e Investigacion

    CABA, Argentina · Recruiting

  • Instituto de Investigacion Clinica TyT

    CABA, Argentina · Recruiting

  • Sanatorio Maipu

    Maipu, Argentina · Recruiting

  • Instituto de Investigaciones Clinicas de Quilmes

    Quilmes, Argentina · Recruiting

  • Sanatorio de la Mujer

    Rosario, Argentina · Recruiting

  • Westmead Hospital

    Westmead, New South Wales, Australia · Not yet recruiting

  • Royal Adelaide Hospital

    Adelaide, South Australia, Australia · Not yet recruiting

  • St Vincent's Hospital Melbourne

    Fitzroy, Victoria, Australia · Not yet recruiting

  • Medizinische Universitaet Innsbruck

    Innsbruck, Austria · Not yet recruiting

Showing 40 of 248 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.